Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02160938 · ClinicalTrials.gov registry record

Prenatal Microarray Follow-Up Study

A clinical trial, sponsored by Columbia University.

Completed
Registry status
184
Enrollment target

NCT02160938 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 184 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02160938 has completed, sponsored by Columbia University.

COMPLETED
Registry status
184 participants
Enrollment target

Study Summary

The objectives of this multi-center collaborative study are to ascertain the frequency of specific copy number variants (CNVs) identified prenatally and to evaluate in detail through continued follow-up of the children the phenotypes associated with CNVs of known or uncertain clinical significance.

Interventions

  • OTHER 3-year follow-up

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2013-02
Est. Completion 2018-12

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT02160938

The ClinicalTrials.gov registry entry for NCT02160938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which 3-year follow-up is the first listed.

NCT02160938 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02160938 about?

NCT02160938 is a clinical study titled "Prenatal Microarray Follow-Up Study". The objectives of this multi-center collaborative study are to ascertain the frequency of specific copy number variants (CNVs) identified prenatally and to evaluate in detail through continued follow-up of the children the phenotypes associated with CNVs of known or uncertain clinical significance.

What is the current status of trial NCT02160938?

This trial is currently completed. The enrollment target is 184 participants. The study started on 2013-02. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02160938?

The interventions under investigation include: 3-year follow-up (OTHER).

Who is sponsoring clinical trial NCT02160938?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.